Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

By Ghavamian R.   Blute M.L.   Bergstralh E.J.   Slezak J.   Zincke H.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

By Cookson M.S.   Fleshner N.E.   Soloway S.M.   Fair W.R.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 887-893

Elsevier

Access to resources Recommend Favorite

Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy

By Cadeddu J.A.   Partin A.W.   Epstein J.I.   Walsh P.C.  

Urology, Vol. 50, Iss. 2, 1997-08 ,pp. : 251-255

Elsevier

Access to resources Recommend Favorite

Early detection with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens

By Berger A.   Spranger R.   Steiner H.   Bartsch G.   Horninger W.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 129-129

Elsevier

Access to resources Recommend Favorite

Handling and Pathology Reporting of Radical Prostatectomy Specimens

By Montironi R.   van der Kwast T.   Boccon-Gibod L.   Bono A.V.   Boccon-Gibod L.  

European Urology, Vol. 44, Iss. 6, 2003-12 ,pp. : 626-636

Elsevier

Access to resources Recommend Favorite